Baseline white matter function predicts short-term treatment response in first-episode schizophrenia

J Neuroimaging. 2023 Jul-Aug;33(4):632-643. doi: 10.1111/jon.13101. Epub 2023 Mar 20.

Abstract

Background and purpose: The detection and characterization of functional activities in the gray matter of schizophrenia (SZ) have been widely explored. However, the relationship between resting-state functional signals in the white matter of first-episode SZ and short-term treatment response remains unclear.

Methods: Thirty-six patients with first-episode SZ and 44 matched healthy controls were recruited in this study. Patients were classified as nonresponders and responders based on response to antipsychotic medication during a single hospitalization. The fractional amplitude of low-frequency fluctuation (fALFF), regional homogeneity (ReHo), and functional connectivity (FC) of white matter were calculated. The relationships between functional changes and clinical features were analyzed. In addition, voxel-based morphometry was performed to analyze the white matter volume.

Results: One-way analysis of variance showed significant differences of fALFF and ReHo in the left posterior thalamic radiation and left cingulum (hippocampus) in the patient group, and the areas were regarded as seeds. The FC was calculated between seeds and other white matter networks. Compared with responders, nonresponders showed significantly increased FC between the left cingulum (hippocampus) and left posterior thalamic radiation, splenium of corpus callosum, and left tapetum, and were associated with the changes of clinical assessment. However, there was no difference in white matter volume between groups.

Conclusion: Our work provides a novel insight that psycho-neuroimaging-based white matter function holds promise for influencing the clinical diagnosis and treatment of SZ.

Keywords: first-episode schizophrenia; functional connectivity; resting-state functional magnetic resonance imaging; treatment response; white matter.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain
  • Cerebral Cortex
  • Gray Matter / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging / methods
  • Schizophrenia* / diagnostic imaging
  • Schizophrenia* / drug therapy
  • White Matter* / diagnostic imaging